Semaglutide GLP-1, initially developed for managing type 2 diabetes, has been FDA-approved since June 2021 for chronic weight management in adults with obesity or those who are overweight and have at least one weight-related condition such as hypertension, type 2 diabetes, or hyperlipidemia
Compounded GLP-1s are prepared by specialized pharmacies to meet a patients specific needs when commercially available products are not suitable or accessible
Oxytocin, a nine amino acid neuropeptide, plays an important role in social behavior [85,86,87,88]
This activation upregulates tyrosinase and related enzymes that control pigment synthesis[2]
Sometimes, including a GLP-1 probiotic alongside Semaglutide or Tirzepatide can lower the side effects linked to those meds
"Effects of Green Tea Extract on Insulin Resistance and Glucagon-Like Peptide 1 in Patients with Type 2 Diabetes." PLoS ONE